Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$60.22 USD

60.22
11,672,946

-0.81 (-1.33%)

Updated Jun 14, 2024 04:00 PM ET

After-Market: $60.22 0.00 (0.00%) 6:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (232 out of 249)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Has CVS Health (CVS) Outpaced Other Retail-Wholesale Stocks This Year?

Is (CVS) Outperforming Other Retail-Wholesale Stocks This Year?

6 Promising Price-to-Book Value Stocks to Buy Now

P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.

Pharmacies & Drug Stores Industry Outlook: Prospects Look Weak

Pharmacy retailers are gradually realizing the growing market demand for Medicare plan options. This apart, they are aggressively emphasizing on chronic disease care and management.

Zacks.com featured highlights include: ArcBest, American Airlines, Cardinal, Century Aluminum and CVS

Zacks.com featured highlights include: ArcBest, American Airlines, Cardinal, Century Aluminum and CVS

The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker

The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker

Here's Why You Should Add CVS Health to Your Portfolio Now

CVS Health (CVS) is optimistic about synergies from Aetna deal which will help create a robust platform to serve individuals better.

Sweta Killa headshot

Is Deep Value ETF (DVP) a Strong ETF Right Now?

Smart Beta ETF report for DVP

Should Value Investors Buy CVS Health (CVS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

5 Broker Favorite Stocks to Watch Out For

The task of designing one's portfolio to include potential outperformers is not an easy one. Broker advice is necessary to design a winning portfolio.

Mark Vickery headshot

Top Analyst Reports for UnitedHealth, CVS Health & General Electric

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), CVS Health (CVS) and General Electric (GE).

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed the most recent trading day at $65.53, moving +0.52% from the previous trading session.

Benjamin Rains headshot

Amazon Posts Record-Breaking Holiday Sales: Time to Buy AMZN Stock?

Shares of Amazon (AMZN) popped 5% in morning trading the day after Christmas after the e-commerce powerhouse said that its customers made more purchases worldwide than ever before during the holiday season. The question now is should investors consider buying Amazon stock on the dip as we move into 2019?

Swarup Gupta headshot

5 Great Healthcare Stocks to Buy for 2019

Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.

CVS Health (CVS) Stock Moves -1.22%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $62.92, marking a -1.22% move from the previous day.

Rite Aid (RAD) Stock Up on Q3 Earnings Beat, FY19 View Down

Rite Aid's (RAD) top and bottom lines improve year over year. Also, earnings came ahead of the Zacks Consensus Estimate but sales lagged the same.

CVS Health (CVS) Stock Moves -1.66%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $70.69, marking a -1.66% move from the previous day.

Benjamin Rains headshot

Buy Amazon (AMZN) Stock on the Dip Heading into 2019?

Amazon (AMZN) stock has fallen over 16% in the last three months as part of the larger market pullback driven by the likes of Apple (AAPL) and other giants. The company's days of 40% top-line growth might also be over. But let's dive into Amazon's overall business picture and outlook to see if investors should buy AMZN stock heading into 2019.

CVS Health Aetna Synergy Impressive, PBM Selling Season Solid

CVS Health (CVS) estimates a $750-million earning from near-term synergies with low- to mid-single digit addition in the second year after the closure of Aetna transaction.

The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle

The Zacks Analyst Blog Highlights: UnitedHealth, Broadcom, CVS Health, FedEx and Oracle

Benjamin Rains headshot

Here's What to Expect from Facebook (FB) Stock in 2019

Facebook's (FB) 2018 might be a year investors want to forget. But the social media powerhouse will hopefully use it as a lesson to help move forward. The question now is what should we expect from Facebook in 2019?

Mark Vickery headshot

Top Analyst Reports for UnitedHealth, Broadcom & CVS Health

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Broadcom (AVGO) and CVS Health (CVS).

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $73.34 in the latest trading session, marking a -1.01% move from the prior day.

Why Is CVS Health (CVS) Up 0.2% Since Last Earnings Report?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ryan McQueeney headshot

Mixed Trade War Signals, the Moonves Scandal, & CVS' Drug Price Plan

Ryan McQueeney discusses the latest drama in the U.S.-China trade war, new developments in Les Moonves' departure from CBS, and a new drug pricing plan from pharmacy giant CVS.

CVS Health (CVS) Stock Moves -0.77%: What You Should Know

CVS Health (CVS) closed at $78.91 in the latest trading session, marking a -0.77% move from the prior day.